Overview

Ketamine and Lidocaine Infusion in Refractory Chronic Migraine

Status:
NOT_YET_RECRUITING
Trial end date:
2026-12-01
Target enrollment:
Participant gender:
Summary
Ketamine and lidocaine infusion for refractory chronic migraine: Comparative Study
Phase:
EARLY_PHASE1
Details
Lead Sponsor:
Assiut University
Treatments:
Glucose
Water